New Sanofi chief Paul Hudson takes the ax to his executive committee, chopping 4 key players
Sanofi’s new CEO is jettisoning 4 top execs from the pharma giant’s executive committee as he reorganizes the company and attempts a reboot of the global organization. And each of them were promoted to their current positions over the last 2 or 3 years, as ex-CEO Olivier Brandicourt tried to put his own stamp on the company.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 87,800+ biopharma pros reading Endpoints daily — and it's free.